TMEM201 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.910000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.461600E-01
Normal-vs-Stage2
4.372200E-01
Normal-vs-Stage3
5.224000E-02
Normal-vs-Stage4
7.415400E-01
Stage1-vs-Stage2
7.282300E-02
Stage1-vs-Stage3
1.096770E-01
Stage1-vs-Stage4
6.005400E-01
Stage2-vs-Stage3
1.180250E-01
Stage2-vs-Stage4
5.436800E-01
Stage3-vs-Stage4
8.418300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.313900E-02
Normal-vs-AfricanAmerican
8.618600E-01
Normal-vs-Asian
5.726800E-01
Caucasian-vs-AfricanAmerican
6.946400E-01
Caucasian-vs-Asian
9.944000E-01
AfricanAmerican-vs-Asian
6.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.959800E-02
Normal-vs-Female
2.625800E-01
Male-vs-Female
3.646800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.582000E-01
Normal-vs-Age(41-60Yrs)
5.552800E-01
Normal-vs-Age(61-80Yrs)
2.944100E-02
Normal-vs-Age(81-100Yrs)
4.095400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.247200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.785410E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.769000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.491180E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.274400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.664000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.672790E-01
Normal-vs-Daily Drinker
7.322800E-01
Normal-vs-Weekly Drinker
5.426200E-01
Normal-vs-Occasional Drinker
9.249600E-01
Normal-vs-Social Drinker
6.658400E-01
Non Drinker-vs-Daily Drinker
3.234000E-02
Non Drinker-vs-Weekly Drinker
6.526200E-02
Non Drinker-vs-Occasional Drinker
7.361600E-02
Non Drinker-vs-Social Drinker
1.018610E-01
Daily Drinker-vs-Weekly Drinker
3.640000E-01
Daily Drinker-vs-Occasional Drinker
7.051000E-01
Daily Drinker-vs-Social Drinker
8.250800E-01
Weekly Drinker-vs-Occasional Drinker
5.480400E-01
Weekly Drinker-vs-Social Drinker
3.221400E-01
Occasional Drinker-vs-Social Drinker
6.210000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.552400E-01
Normal-vs-Grade 2
6.843200E-01
Normal-vs-Grade 3
6.771400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.301570E-01
Grade 1-vs-Grade 3
1.039390E-01
Grade 1-vs-Grade 4
7.552400E-01
Grade 2-vs-Grade 3
6.375600E-01
Grade 2-vs-Grade 4
6.843200E-01
Grade 3-vs-Grade 4
6.771400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.765600E-01
Normal-vs-NonDiabetic
2.816800E-01
Diabetic-vs-NonDiabetic
1.431600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.300800E-01
Normal-vs-NoPancreatitis
1.441560E-01
Pancreatitis-vs-NoPancreatitis
9.211800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.197800E-01
Normal-vs-N1
4.783400E-01
N0-vs-N1
2.117000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.493600E-01
Normal-vs-TP53-NonMutant
6.396200E-01
TP53-Mutant-vs-TP53-NonMutant
4.458600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
